(Reuters) -Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor demand.
The Mountain View, California-based company is now looking to raise up to $300 million by offering 16.7 million shares priced between $17 and $18 apiece.
It had earlier offered 12.5 million shares priced between $15 and $17 apiece.
Heartflow is among a string of companies racing to go public before the annual August lull kicks in.
J.P. Morgan, Morgan Stanley and Piper Sandler are the lead underwriters for the offering.
Heartflow will list on the Nasdaq under the symbol “HTFL”.
(Reporting by Arasu Kannagi Basil in Bengaluru; Editing by Shilpi Majumdar)
Comments